|
|
|
Volumn 6, Issue 4, 1996, Pages 203-205
|
|
The French experience with infusional 5-FU in gastric and pancreatic cancer.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CA 19-9 ANTIGEN;
CARCINOEMBRYONIC ANTIGEN;
CISPLATIN;
FLUOROURACIL;
TUMOR ANTIGEN;
TUMOR MARKER;
ADENOCARCINOMA;
ADULT;
AGED;
ARTICLE;
BLOOD;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
DRUG ADMINISTRATION;
FEMALE;
GRAM NEGATIVE INFECTION;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
MALE;
METASTASIS;
MIDDLE AGED;
MORTALITY;
NEUTROPENIA;
PANCREAS TUMOR;
PATHOLOGY;
PHASE 2 CLINICAL TRIAL;
PROSPECTIVE STUDY;
SEPSIS;
STOMACH TUMOR;
SURVIVAL RATE;
TREATMENT OUTCOME;
ADENOCARCINOMA;
ADULT;
AGED;
ANTIGENS, NEOPLASM;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CA-19-9 ANTIGEN;
CARCINOEMBRYONIC ANTIGEN;
CISPLATIN;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
FLUOROURACIL;
GRAM-NEGATIVE BACTERIAL INFECTIONS;
HUMANS;
INFUSIONS, INTRAVENOUS;
MALE;
MIDDLE AGED;
NEOPLASM METASTASIS;
NEUTROPENIA;
PANCREATIC NEOPLASMS;
PROSPECTIVE STUDIES;
SEPSIS;
STOMACH NEOPLASMS;
SURVIVAL RATE;
TREATMENT OUTCOME;
TUMOR MARKERS, BIOLOGICAL;
|
|
EID: 0030225209
PISSN: 10600051
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (2)
|
|
References (0)
|
